Tempest Raises $2.5M in Discounted Private Placement, Warrants Could Add $5M
TPST is trading near its 52-week low of $0.8 (4.3% above the low).
Summary
Tempest Therapeutics announced a private placement of 3.1 million shares at $0.805 per share, raising $2.5 million upfront with warrants that could bring in another $5 million if exercised. The pricing is a discount to the last close of $0.8343 and comes as the company trades near its 52-week low with a market cap of only $12.8 million. This follows a series of capital raises including a $50 million equity line with Lincoln Park that became effective on September 1, and the company reported just $0.8 million in cash as of August 13. The offering is highly dilutive relative to the company's size and underscores its urgent need for capital to continue operations. Investors should note that the warrants require stockholder approval before they can be exercised, and the company has a history of adjourning meetings due to insufficient votes.
At the time of this announcement, TPST was trading at $0.83 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $12.8M. The 52-week trading range was $0.80 to $12.23. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.